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Ferredoxin:thioredoxin reductase (FTR) is a key reg-
ulatory enzyme of oxygenic photosynthetic cells in-
volved in the reductive regulation of important target
enzymes. It catalyzes the two-electron reduction of the
disulfide of thioredoxins with electrons from ferredoxin
involving a 4Fe-4S cluster and an adjacent active-site
disulfide. We replaced Cys-57, Cys-87, and His-86 in the
active site of Synechocystis FTR by site-directed mu-
tagenesis and studied the properties of the mutated pro-
teins. Mutation of either of the active-site cysteines
yields inactive enzymes, which have different spectral
properties, indicating a reduced Fe-S cluster when the
inaccessible Cys-87 is replaced and an oxidized cluster
when the accessible Cys-57 is replaced. The oxidized
cluster in the latter mutant can be reversibly reduced
with dithionite showing that it is functional. The C57S
mutant is a very stable protein, whereas the C87A mu-
tant is more labile because of the missing interaction
with the cluster. The replacement of His-86 greatly re-
duces its catalytic activity supporting the proposal that
His-86 increases the nucleophilicity of the neighboring
cysteine. Ferredoxin forms non-covalent complexes
with wild type (WT) and mutant FTRs, which are stable
except with the C87A mutant. WT and mutant FTRs form
stable covalent heteroduplexes with active-site modi-
fied thioredoxins. In particular, heteroduplexes formed
with WT FTR represent interesting one-electron-re-
duced reaction intermediates, which can be split by re-
duction of the Fe-S cluster. Heteroduplexes form non-
covalent complexes with ferredoxin demonstrating the
ability of FTR to simultaneously dock thioredoxin and
ferredoxin, which is in accord with the proposed reac-
tion mechanism and the structural analyses.
Ferredoxin:thioredoxin reductase (FTR)1 is the central en-
zyme of the ferredoxin/thioredoxin system, a redox regulatory
mechanism, which enables oxygenic photosynthetic cells to
switch between light and dark metabolism and to adapt to
changes in light intensity (1, 2). It transfers a redox signal
received from ferredoxin to thioredoxins (Trxs) by a unique
mechanism involving a 4Fe-4S cluster and a disulfide bridge,
thereby transforming the signal from an “electron signal” to a
“thiol signal.” Trxs, the regulatory disulfide proteins, transmit
this signal by dithiol-disulfide interchange reactions to certain
enzymes, e.g. chloroplast fructose-1,6-bisphosphatase (3) and
NADP-dependent malate dehydrogenase (4), thereby modify-
ing their catalytic activity through reduction of regulatory di-
sulfide bonds. Most biochemical investigations have been done
on the spinach enzyme, whereas the only three-dimensional
structure was solved for the Synechocystis FTR (5). This en-
zyme shows no functional difference to the spinach protein but
is significantly more stable (6, 7).
The FTR is an unusually thin molecule in the shape of a
concave disk with only 10 Å across the center of the molecule
where the Fe-S cluster and the redox-active disulfide are lo-
cated (8). It contains seven strictly conserved cysteine residues,
six of them organized in two CPC and one CHC motifs. These
six Cys constitute the redox-active disulfide bridge and ligate,
in an unusual arrangement, the Fe-S cluster (9). In the Syn-
echocystis FTR Cys-57 and Cys-87 form the active-site disul-
fide. The four remaining cysteines, Cys-55, Cys-74, Cys-76, and
Cys-85, are ligands to the cluster. This arrangement positions
the redox-active disulfide bridge adjacent to the cluster with
Cys-57 exposed to the solvent on one side of the flat molecule,
whereas Cys-87 is protected. The iron-sulfur center is closer to
the opposite side of the thin molecule. It has been proposed that
the two sides of the molecule represent, respectively, the ferre-
doxin and the Trx docking areas, enabling the FTR to interact
simultaneously with electron donor and acceptor (8).
Based on spectroscopic measurements and on the structure a
two-step reaction mechanism has been proposed for the reduc-
tion of Trx by FTR (8, 10). The first electron, delivered by
ferredoxin on the ferredoxin docking area and transmitted
through the 4Fe-4S, cleaves the active-site disulfide producing
a surface-exposed sulfhydryl (Cys-57) and a cysteine-based
thiyl radical (Cys-87). This radical becomes stabilized by the
covalent attachment of the cysteine to the cluster, forming an
oxidized (3) five-coordinate cluster. Cys-57 then acts as a
nucleophile and attacks the disulfide bond of a Trx, forming a
one-electron-reduced heterodisulfide intermediate. His-86 and
Arg-58, which are very close to the disulfide bridge (3.9 and 5.6
Å, respectively), might increase the nucleophilicity of the cys-
teine. This first reaction anchors the Trx molecule through the
heterodisulfide linkage to the Trx docking area. The ferredoxin
docking area, on the opposite side, stays free for a second
interaction with a reduced ferredoxin. The second electron re-
duces the cluster-ligated Cys-87 and reestablishes the original
2 oxidation state of the cluster. The newly reduced internal
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Cys-87 attacks and cleaves the heterodisulfide linkage between
FTR and Trx, thus liberating the reduced Trx. The closing of
the active-site disulfide bridge completes the reaction cycle.
Alkylation of the accessible cysteine of the active-site disul-
fide (Cys-57 in Synechocystis) with N-ethylmaleimide provided
a stable analogue of the one-electron-reduced heterodisulfide
intermediate (10, 11). This modification is accompanied by a
typical change of the visible spectrum (12) because of the oxi-
dation of the cluster from its 2 state in the resting enzyme to
the 3 state in the analogue of the reaction intermediate.
Recent spectroscopic analyses demonstrated that in the reac-
tion intermediate Cys-87 is coordinated to the closest iron atom
of the cluster (13). In addition there is partial bonding of the
disulfide to this iron even in the resting state of the enzyme.
This promotes charge buildup on this special iron making it an
electron donor with increased ferrous character. The system is
therefore primed and ready to accept an electron from ferredoxin
to break the disulfide bond. The binding of an additional cysteine
to the special iron, in the one-electron-reduced heterodisulfide
intermediate, makes it more ferric, and the charge is drawn away
from it. Thus Cys-87 appears to be a critical residue not only as
a member of the disulfide bridge but also because it interacts
with an iron atom of the cluster in the resting enzyme.
In this study we have produced and characterized mutant
FTRs, based on the Synechocystis protein, to obtain further
information on the function of three important residues. We
individually replaced the redox-active cysteines, Cys-57 by ser-
ine and Cys-87 by serine or alanine, as well as His-86, proposed
to increase the nucleophilicity of the active site, by tyrosine.
The choice of tyrosine was based on sequences of putative FTRs
in two archaebacteria (14, 15). Our results confirm the func-
tions attributed to the two active-site cysteines and provide
evidence that His-86 indeed increases the reactivity of the FTR.
In addition we have used the wild type (WT) as well as the
mutant FTRs to study their interaction with ferredoxin and
Trxs. We obtained non-covalent complexes with ferredoxin,
covalent heterodimeric complexes with Trxs, representing the
one-electron-reduced reaction intermediates, and triple com-
plexes involving all three proteins confirming the protein-pro-
tein interactions postulated based on the structural analyses.
EXPERIMENTAL PROCEDURES
Materials—Restriction endonucleases were from Promega and Bio-
labs, and Taq and Pfu DNA polymerases were from Promega. They
were used according to the manufacturers’ instructions. The custom
oligonucleotides were obtained from Microsynth AG (Balgach, Switzer-
land). Chromatography supports and FPLC equipment were from Am-
ersham Biosciences. All chemicals were of analytical grade.
Site-directed Mutagenesis—The construction of the mutant proteins
was based on the dicistronic construct for the expression of the FTR
from Synechocystis sp. PCC6803 described earlier (6, 16).
Mutagenesis was performed by PCR. The three mutations C87S,
C87A, and H86Y were introduced by directly amplifying the entire
expression vector using the following oligonucleotides (mutations in
bold): C87S antisense, 5-AAACAACATAGAGTGACATTC-3; C87A
antisense, 5-AAACAACATAGCGTGACATTC-3; H86Y antisense, 5-
AAACAACATACAGTAACATTC-3; and SUB1 sense, 5-TTAACCCCA-
GATAACGATTTTG-3. For the introduction of the fourth mutation,
C57S, two successive amplifications were necessary as described for the
spinach FTR (7). In a first amplification, using the primers C57S
antisense, 5-GTGGCGAGAGGGGCACA-3, and T7 sense, 5-AATAC-
GACTCACTATAG-3, a megaprimer was obtained containing the infor-
mation for the variable and part of the catalytic subunit including the
mutation. In a second amplification using the megaprimer and T7term
antisense 5-GCTAGTTATTGCTCAGCGG-3, the dicistronic construct
was rebuilt and could be inserted into the pET-3c expression plasmid.
All sequences and mutations were checked by automatic sequencing
using either the T7 or T7term primers and the sequencing kit from
Amersham Biosciences on a MWG LICOR sequencer.
Protein Expression and Purification—Expression of recombinant
proteins was done in Escherichia coli cells grown in Luria broth at 37 °C
either in a 1.5-liter (MultiGen, New Brunswick, CT) or 10-liter fer-
menter (Model L1523, Bioengineering AG), sparged with air, and
stirred at 500 rpm.
Spinach fructose-1,6-bisphosphatase and Trx f WT as well as the
C49S mutant were expressed and purified as described earlier (17).
Mutant spinach Trx m C40S was constructed based on Trx mc (18) by
PCR, and the product was cloned into the expression plasmid pET-3c
and expressed in E. coli strain BL21(DE3) (19). It was purified to
homogeneity as described earlier (20). Recombinant Synechocystis
ferredoxin was constitutively expressed in E. coli cells (strain DH5a
from Invitrogen), transformed with the expression vector pCK5/19 (gift
from Herbert Bo¨hme, University of Bonn), and grown overnight in the
presence of 50 M FeSO4 and 100 g/ml ampicillin. The purification of
ferredoxin was achieved through hydrophobic interaction, size exclu-
sion, and anion exchange chromatography. Ferredoxin:NADP reduc-
tase (FNR) from spinach leaves has been purified to homogeneity.
WT and mutant Synechocystis FTRs were expressed in the E. coli
strain BL21(DE3)pLysS in the presence of 50 g/ml ampicillin, 34
g/ml chloramphenicol, and 10 mM glucose. When the culture reached
an A600 nm of 6–7, expression was induced by adding isopropyl--D-
thiogalactopyranoside to a final concentration of 0.2 mM, and 2 h later
cells were harvested by centrifugation (2400  g, 6 min, 4 °C). The
purification of the FTR was done as described elsewhere (16).
Analytical Procedures—Spectrophotometry was performed with a
PerkinElmer Lambda 16 instrument. Difference spectra were recorded
in dual-compartment cuvettes with compartment path lengths of 0.438
cm. Thiol determinations were done according to Habeeb (21). The
activity of FTR was measured by its capacity to activate fructose-1,6-
bisphosphatase, using dithionite-reduced benzyl viologen as the elec-
tron donor for the FTR as described earlier (22). Gel electrophoretic
analyses of the heteroduplexes were done under non-denaturing condi-
tions in a Mini-Protean (Bio-Rad) with the buffer system described by
Laemmli (23), omitting SDS and 2-mercaptoethanol, however.
Dissociation of the WT FTR-Trx f heteroduplex by the thylakoid
system was achieved in a 200-l incubation mixture containing 100 mM
Tris-Cl, pH 7.9, 10 mM sodium ascorbate, 0.2 mM 2,6-dichloroindophe-
nol, 10 M ferredoxin, 40 M WT FTR-Trx f heteroduplex, and spinach
thylakoids equivalent to 100 g of chlorophyll. After equilibration with
argon for 5 min in the dark at 25 °C, the mixture was illuminated for 10
min. Thylakoids were removed by centrifugation, and the 50-l super-
natant was separated on a Superdex-75 HR 10/30 column.
Redox titrations were performed by incubating heteroduplexes in
mixtures of oxidized and reduced DTT of defined redox potentials (24)
followed by analysis of the mixtures by native gel electrophoresis, which
separates heteroduplexes from free FTR and Trxs. This experimental
approach provided very reproducible results allowing a good estimate of
the redox potential. Incubations were done with 50 M heteroduplex in
300 mM Tris-Cl, pH 7.0, and 100 mM DTT under argon at room tem-
perature. Equilibrium was reached after 2 h when samples, large
enough to easily visualize the proteins, were removed and analyzed on
15% native polyacrylamide gels.
Heteroduplex Formation—Small amounts of heteroduplex were ob-
tained by incubating equimolar solutions of FTR and Trx in 20 mM
triethanolamine-Cl buffer, pH 7.3, for 2–4 h at room temperature.
Larger quantities of heteroduplex were prepared by mixing FTR (up to
2 mol) and a 1.2–1.5-fold excess of Trx in 20 mM triethanolamine-Cl
buffer, pH 7.3, and 100 mM DTT to reduce possible mutant Trx ho-
modimers. The mixture was concentrated to about 5 ml in an Amicon
ultrafiltration cell (Model 12) fitted with an YM-10 membrane and
diafiltered with 10 volumes of the above buffer without DTT. The
diafiltered solution was transferred to a beaker permitting good oxy-
genation and slowly stirred overnight at 4 °C. Then the heterodimer
was separated from free FTR and Trx by ion exchange chromatography
on a Q-Sepharose HiLoad column and finally concentrated and diafil-
tered with 20 mM triethanolamine-Cl buffer, pH 7.3.
RESULTS
Production and Purification—The WT and mutant Synecho-
cystis FTRs were well expressed in E. coli and could be purified
by our standard procedure except for the C87S mutant. This
mutant, although produced in E. coli as evidenced by immuno-
blotting, could not be purified. The Cys to Ser mutation appar-
ently generates an unstable protein, whereas the C87A muta-
tion yields a more stable protein. We obtained yields of purified
proteins in the range of 7–27 mg/liter of bacterial culture.
Spectral Characterization—WT FTR has a typical UV-visible
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absorbency spectrum, which is characteristic of the 4Fe-4S
cluster in its 2 redox state and its interactions with the
redox-active disulfide bridge (16). Changes in the environment
of the Fe-S cluster are therefore expected to influence the
spectral properties. Fig. 1A shows the spectra of the WT and
the three mutant proteins, and Table I lists their molar absor-
bencies at 408 nm and the spectral ratios at 408/278 and
408/345 nm calculated from the spectra. The spectra of the
mutants C87A and H86Y are very similar to that of the WT
protein, except for small differences in the absorbency ratios. In
the case of the H86Y mutant the lower 408/278 ratio is ex-
plained by the presence of the additional tyrosine. The spec-
trum of the C57S mutant is clearly different from that of the
WT FTR, identical to the one observed with the N-ethylmale-
imide-modified FTR (11, 12), and appears to be caused by the
oxidation of the Fe-S cluster to its 3 redox state. This has
been verified by treating WT and mutant proteins with dithio-
nite. Comparable with what was reported earlier for the WT
protein (11), we observed no change in the C87A or H86Y FTR
spectra. However, reduction of mutant C57S clearly transforms
its spectrum to the type observed with WT FTR as isolated,
indicating that the cluster is in the 2 redox state (Fig. 1B).
During oxidation of the added dithionite, because of the pres-
ence of oxygen in the cuvette, the spectrum of the C57S mutant
shifts back to its original oxidized form.
Changes of the spectra of the four proteins over time were
used to compare their stability in solution, an approach already
applied successfully to the spinach FTR (7). These results (data
not shown) indicate that the C57S mutant has the most stable
conformation. The WT and H86Y mutant are about equally
stable but less than the C57S. The C87A mutant is signifi-
cantly more labile, progressively losing its color during incuba-
tion, which indicates that the Fe-S cluster disintegrates.
Thiol Determinations—The accessible and total thiols have
been determined by reacting the proteins with 5,5-dithiobis(2-
nitrobenzoic acid) in the absence and presence of SDS to verify
the correctness of the mutations and the intactness of the
structures. For the WT and the mutants H86Y and C57S the
experimentally determined values correspond to the theoreti-
cally expected numbers, i.e. one accessible and five total thiols
in the WT and H86Y FTR, and one accessible and six total
thiols in the C57S mutant. For the C87A mutant the expected
two accessible thiols were found; however, there were only four
instead of six total Cys residues. This might be because of the
formation of an artifactual disulfide bond in this less stable
mutant under our aerobic assay conditions.
Activity—The catalytic activity of the mutants was measured
as their capacity to activate fructose-1,6-bisphosphatase and
compared with that of the WT protein. As expected, the two
mutations modifying the active-site disulfide, C57S and C87A,
completely abolish activity. The mutant H86Y had only 10%
of the WT activity when tested under comparable conditions.
Non-covalent Interaction with Ferredoxin—Synechocystis
FTR and ferredoxin form a 1:1 complex resulting in a typical
difference spectrum with a peak at 460 nm and a trough at 410
nm (Fig. 2A, inset). We titrated the Synechocystis FTR mutants
with ferredoxin to verify whether the mutations influence this
protein-protein interaction. The results show that at a low salt
concentration all mutants form a 1:1 complex like the WT
protein (Fig. 2A). These complexes are stabilized by electro-
static interactions and have a high affinity, because concentra-
tions above 200 mM NaCl had to be added to observe a deviation
from linearity in the formation of the complexes. Curiously,
with the mutant C87A the absorbency difference due to the
complex started to decrease when ferredoxin above an equimo-
lar ratio was added (Fig. 2B).
Interaction with Thioredoxins through Formation of Cova-
lent Heteroduplexes—Reduction of Trxs proceeds via the forma-
tion of a transient, covalent heteroduplex between FTR and
Trx. This intermediate complex can be stabilized using mu-
tants in which one or both non-accessible Cys of the participat-
ing disulfide bridges are modified. We used mutant Trxs f C49S
and m C40S as well as WT and all three mutant FTRs to study
the formation of such heteroduplexes. Their presence could be
demonstrated by chromatography and by native gel electro-
phoresis followed by immunoblotting. SDS-PAGE was not
suited for these analyses because of artifactual S–S bond for-
mation upon denaturation under oxidizing conditions leading
to multiple bands. When the WT FTR as well as the mutants
C87A and H86Y are incubated with Trx f C49S a new band
appears upon electrophoretic analysis. This band is colored,
clearly visible during migration like the band representing
FTR, and reacts with antibodies against Trx f indicating that it
represents the heteroduplex. Similar results were obtained with
WT FTR and mutant Trx m. When dithiothreitol is added to the
electrophoresis samples the heteroduplex band disappears. Upon
incubation of the FTRs with WT Trx f, no heteroduplex is formed.
Also the FTR C57S mutant did not form a heteroduplex, because
its interacting Cys had been replaced. We observed, however,
that in the presence of Trx f C49S, the C57S mutant was de-
graded. This was verified by following the A408/A278 absorbency
ratio of an equimolar mixture of the two proteins. Fig. 3A shows
that the ratio decreases because of the disintegration of the Fe-S
cluster leading to a degradation of the protein, whereas the ratio
of FTR incubated alone does not change.
FIG. 1. UV-visible absorbency spectra. A, spectra of WT and three
mutant FTRs, normalized at 278 nm. B, spectra of oxidized and reduced
C57S mutant FTR. The peak at 315 nm is caused by excess dithionite.
For the dithionite corrected spectrum the absorbency of dithionite has
been subtracted.
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The heteroduplexes were separated from the unreacted pro-
teins by chromatography. Whereas gel filtration did not com-
pletely resolve heteroduplex and FTR, because of the relatively
small difference in molecular mass, ion exchange chromatog-
raphy provided quantitative separation of all proteins engaged
in the reaction (Fig. 4). This approach enabled us to purify and
characterize the heteroduplexes and to use them for interaction
studies with ferredoxin.
The visible absorbency spectra of free and Trx-complexed FTR
C87A are identical (compare in Table I). By contrast, the spectra
of the heteroduplexes formed with WT or H86Y mutant FTR are
comparable with the spectra of N-ethylmaleimide-modified FTR
or mutant C57S (Fig. 1). This suggests that the redox state of the
cluster is altered. The spectral change, which is most pronounced
at 345 nm, provided a useful measure to follow complex forma-
tion over time as documented in Fig. 3B for the reaction with Trx
m C40S. Similar results were obtained with Trx f C49S. A com-
parison of the kinetics between WT FTR and mutant H86Y
reveals that the mutant FTR reacts more slowly.
TABLE 1
Spectral properties of WT and mutant FTRs and of FTR-Trx heteroduplexes
FTR Color 408 nm
Spectral ratio
408/278 nm 408/345 nm
M
1 cm1
WT Brown-green 17,400 0.44 0.94
C87A Brown-green 17,400 0.44 1.00
H86Y Brown-green 17,400 0.41 0.96
C57S Brown-red 18,700 0.47 0.78
WT-Trx f Brown-red 0.35 0.78
WT-Trx m Brown-red 0.30 0.78
C87A-Trx f Brown-green 0.29 1.00
FIG. 2. Complex formation between FTR and ferredoxin. WT
(A) and mutant (B) FTR were titrated with ferredoxin in 20 mM trieth-
anolamine-Cl buffer, pH 7.3, at 25 °C. Inset, difference spectrum of the
complex FTR-ferredoxin at 23 M. Difference spectra were recorded
using dual compartment cuvettes. To the solution of about 50 M FTR
in the measuring cuvette small aliquots of ferredoxin were added. In the
reference cuvette corresponding aliquots of ferredoxin were added to
buffer in one compartment and aliquots of buffer to the solution of FTR
in the second compartment. After 5 min of equilibration, three spectra
from 550 to 350 nm were recorded for each data point, and the differ-
ence was calculated from the averaged absorbencies at 460 and 410 nm
corrected for dilution. Upper axis represents the ferredoxin/FTR ratio
calculated with the exact protein concentrations.
FIG. 3. Kinetic analyses of FTR-Trx interactions. A, change of
the absorbency ratio during incubation of an equimolar mixture of FTR
C57S and Trx f C49S in 20 mM triethanolamine-Cl buffer, pH 7.3, at
25 °C (squares). As a control, FTR C57S was incubated alone under the
same conditions (circles). Absorbency readings at 408 and 278 nm were
taken automatically at 100-min intervals. B, comparison of the rate of
heteroduplex formation between WT or H86Y mutant FTR and Trx m
C40S. 15 nmol of FTR were incubated with 20 nmol of Trx m C40S in 1
ml of 20 mM triethanolamine-Cl buffer, pH 7.3, at 25 °C in spectropho-
tometer cuvettes. The reaction mixture contained, in addition, 14 mM
2-mercaptoethanol to keep the mutant Trx monomeric. The percentage
of heteroduplex formed was calculated from the change of the 408/345
nm absorbency ratio. Continuous line, FTR WT-Trx m C40S; broken
line, FTR H86Y-Trx m C40S.
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On the Trx interaction side of the FTR, Cys-30 represents an
accessible thiol. A titration of accessible thiols in the heterodu-
plexes by 5,5-dithiobis(2-nitrobenzoic acid) can therefore pro-
vide some information about the coverage of this surface by
Trx. In the FTRTrx f complex one thiol was found; however,
none was found in the complex with Trx m. Because Trx f
contains an accessible Cys on its surface and Trx m has none
(25), this result suggests that Cys-30 on the FTR surface is
masked by the bonded Trx.
The heteroduplex between WT FTR and Trx represents a
stable reaction intermediate with an oxidized Fe-S cluster. Its
reduction should dissociate Trx from FTR, which can be shown
by gel filtration. It is assumed that in the chloroplast, light-
reduced ferredoxin delivers the electron necessary to reduce
the Fe-S cluster and thereby breaks the disulfide bond linking
the two molecules. We have therefore incubated the WT FTR-
Trx heteroduplex with ferredoxin, thylakoids, and ascorbate/
dichlorophenol-indophenol as electron source and observed
complete dissociation in the light. However, control experi-
ments showed that ferredoxin is not required and that even in
the dark, partial dissociation is obtained. In vitro ferredoxin
can also be reduced via FNR with an excess of NADPH  H.
In this reduction system both FNR and NADPH  H in a
50-fold excess over the heteroduplex were needed to obtain
dissociation. Here again, the presence of ferredoxin was not
required.
We have also compared the effect of different chemical re-
ductants on the dissociation of the WT FTR-Trx f or m hetero-
duplex by gel electrophoresis and spectrophotometry. Reduced
glutathione had no effect and mercaptoethanol had only a weak
effect at concentrations of a 1000-fold excess over the hetero-
duplex. DTT, at a 200-fold excess, was more efficient, showing
a dissociation kinetic with a 50-min lag phase. Dithionite was
the most efficient. A 40-fold excess immediately broke the
disulfide bond linking the two proteins and reestablished the
spectrum of free WT FTR. When the FTR(C87A)-Trx f hetero-
duplex was similarly treated with dithionite, Trx f was not
dissociated.
Redox Potentials of the Intermolecular Disulfide Bonds—The
FIG. 5. Redox potential determination of FTR-Trx heterodu-
plexes. The heteroduplexes, at 50 M, were incubated under argon in
300 mM Tris-Cl, pH 7.0, containing 100 mM mixtures of oxidized and
reduced DTT of defined redox potentials. After 2 h, samples correspond-
ing to 200 pmol were separated by native gel electrophoresis on a 15%
gel. Top gel, heteroduplex FTR-Trx f. Bottom gel, heteroduplex FTR-Trx
m. a, heteroduplex control without DTT; b, FTR control; c, Trx f; d,
heteroduplex FTR-Trx f; e, free FTR; f, heteroduplex FTR-Trx m; g, Trx
m; h, free FTR. The redox potentials are given in millivolts.
FIG. 6. Chromatographic analysis of the ferredoxin-FTR-Trx
triplex. Protein mixtures were separated by gel filtration on a Super-
dex 75 HR 10/30 column. The samples, 1 nmol of ferredoxin-FTR(WT)-
Trx m triplex (Triplex), FTR(WT)-Trx m heteroduplex (Duplex), or
ferredoxin were chromatographed in a buffer containing 20 mM trieth-
anolamine-Cl, pH 7.3, 50 mM NaCl at a flow rate of 1.0 ml/min. The
elution volumes are indicated above the peaks.
FIG. 4. Chromatographic analyses of FTR-Trx heteroduplex. A,
analytical gel filtration by FPLC on a Superdex 75 HR 10/30 column.
The samples were chromatographed Trx f, FTR(WT), and FTR(WT)-Trx
f heteroduplex in a buffer containing 50 mM potassium Pi, pH 7.0, 150
mM NaCl at a flow rate of 1.0 ml/min. The elution volumes and the
corresponding molecular masses calculated from calibration runs are
indicated above the peaks. B, separation of FTR(WT)-Trx f heterodu-
plex from non-reacted proteins by ion-exchange chromatography on a
FPLC Mono Q HP 5/5 column. The proteins were eluted with a gradient
of 20 ml of 0–500 mM NaCl in 20 mM triethanolamine-Cl, pH 7.3, buffer.
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above results suggest that it should be possible to estimate the
redox potential of the intermolecular disulfide bridge by com-
paring the dissociation of the FTR-Trx heteroduplex at differ-
ent ambient redox potentials. We equilibrated the heterodu-
plexes in incubation mixtures of known redox potentials and
subsequently analyzed them by gel electrophoresis. Fig. 5
shows the results obtained with the heteroduplexes between
WT FTR and Trx f or m, which indicate a potential of 270 
10 mV for the complex with Trx f and280 10 mV for the one
with Trx m. With the FTR(C87A)-Trx f duplex we observed only
partial dissociation down to 390 mV.
Formation of a Triple Complex among FTR, Trx, and Ferre-
doxin—According to the proposed reaction mechanism, the
FTR should be able to interact simultaneously with Trx and
ferredoxin. We therefore were looking for evidence of complex
formation between the heteroduplex FTR-Trx and ferredoxin
by gel filtration and spectrophotometry. When an equimolar
mixture of FTR-Trx m heteroduplex and ferredoxin was chro-
matographed at low ionic strength (Fig. 6), a single peak (tri-
plex) eluted from the column at a lower elution volume (9.3 ml)
than either the heteroduplex (9.7 ml) or ferredoxin (11.16 ml).
When the molar ratio in the mixture was modified to 2:1 in
favor of ferredoxin, a peak of free ferredoxin appeared, and
when the ratio was changed in the opposite direction, a shoul-
der on the profile of the triplex indicated free heteroduplex.
Identical elution profiles were obtained with the FTR-Trx f
heteroduplex. These observations are corroborated by differ-
ence spectroscopy. Both heteroduplexes were titrated with
ferredoxin at 0 M NaCl, and we obtained titration curves iden-
tical to the one shown in Fig. 2A indicating a non-covalent
complex between one ferredoxin and one heteroduplex mole-
cule. These results clearly demonstrate that FTR is capable of
interacting simultaneously with Trx and ferredoxin forming a
1:1:1 complex.
DISCUSSION
The FTR has structural features that are unique and enable
this enzyme to reduce disulfides with electrons from a Fe-S
cluster. This reduction is possible because of the close proxim-
ity and the interactions of the two important catalytic struc-
tures, the 4Fe-4S cluster and the redox-active disulfide bridge.
The structural analyses show that Cys-57, which is part of
the redox-active disulfide, is close to the protein surface and
should act as the attacking nucleophile in the reduction of Trx
(5, 8, 9). We have replaced this Cys with a Ser residue, which
leaves Cys-87, the buried partner residue of the disulfide
bridge, as a free thiol. The mutant protein is no more active and
has the same spectral characteristics as the N-ethylmaleimide-
modified FTR. This indicates that the Fe-S cluster is in its
oxidized state with one of its iron atoms forming a fifth ligation
to the sulfur of Cys-87. This appears to be a favorable confor-
mation rendering the mutant by itself more stable than the WT
protein. The mutant protein can be reversibly reduced with
dithionite, and this is accompanied by a change of the spectrum
to that of the resting WT enzyme. Thereby Cys-87 becomes
reduced and switches from being a cluster ligand to a thiol or
thiolate. The ferredoxin interaction surface appears to be un-
altered, because the protein forms the 1:1 non-covalent com-
plex with ferredoxin like the WT FTR. However, with Trxs no
complex formation is observed, confirming that Cys-57 is part
of the intermolecular disulfide and that Cys-30 on the Trx
interaction surface is not involved in any covalent interaction.
Surprisingly, in the presence of the mutant Trx f C49S, the
FTR C57S loses color indicating a degradation of the Fe-S
cluster. We do not know whether this is caused by the non-
covalent contact of the two proteins or by some interaction
between the accessible cysteines on the protein surfaces.
The partner residue of the redox-active disulfide, Cys-87, is
very close to an iron atom of the cluster and apparently crucial
for its stability. In the resting state of the enzyme the sulfur
shows some weak interaction with this iron and becomes its
fifth ligand in the one-electron-reduced intermediate (13). Re-
placing the sulfur by a hydroxyl in the C87S mutant perturbs
this interaction and renders the cluster, and as a consequence
the whole protein, unstable. This has also been observed with
the spinach FTR (7). By contrast, the introduction of a hydro-
phobic side chain, the C87A mutation, appears to be compatible
with the cluster. However, this enzyme is significantly less
stable than the WT or the other mutant FTRs. This mutant
shows a spectrum very similar to the resting WT FTR. The
small deviation in the 408/345 absorbency ratio might be be-
cause of the missing interaction between the cluster iron and
residue 87. Through its free Cys-57 this mutant FTR forms
covalent heteroduplexes with Trxs.
His-86 is located between a Cys liganding the Fe-S cluster
and the buried inaccessible Cys of the active site. Based on its
properties and on structural considerations we proposed that it
might increase the nucleophilicity of the active-site Cys-57 (8).
Our present results seem to confirm this hypothesis. The H86Y
mutant showed a low catalytic activity in the activation of
fructose-1,6-bisphosphatase, and the kinetic of heteroduplex
formation with Trx was clearly slower than with the WT FTR.
The other properties of this mutant were comparable with
those of the WT protein.
An interesting aspect of these studies was the formation of
SCHEME 1
SCHEME 2
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protein-protein complexes among ferredoxin, FTR, and Trx. A
non-covalent complex between FTR and ferredoxin has already
been reported for the spinach proteins (26, 27). We observed
identical high affinity 1:1 complexes between Synechocystis
ferredoxin and WT, as well as all three mutant FTRs. These
complexes were stable except for the one with the C87A mutant
FTR. Here a disintegration of the cluster was observed when a
1:1 ratio of the two proteins was reached. Because the interac-
tion between a cluster iron and the sulfur of Cys-87 is missing,
the cluster is probably more labile and not able to withstand
the slight deformation due to the electrostatic forces stabilizing
the complex.
We have obtained stable covalent heteroduplexes between
active-site mutant Trxs (Trx f C49S or Trx m C40S) and FTR,
WT, or mutants H86Y and C87A but not mutant C57S. The
visible absorbency spectrum of the heteroduplex with the ac-
tive-site mutant C87A is indistinguishable from the spectrum
of the free mutant FTR. The absence of any change suggests
that the cluster stays in its 2 redox state and that the cova-
lent attachment of Trx f has no influence on the cluster. By
contrast, heteroduplexes formed with either WT or H86Y FTR
have visible absorbency spectra that superimpose with the
spectrum of the C57S mutant or N-ethylmaleimide-modified
FTR. This implies that the cluster has become oxidized, and the
sulfur of Cys-87 has connected to an iron atom of the cluster as
a fifth ligand thus stabilizing the heteroduplex.
The mechanisms of heteroduplex formation with either mu-
tant C87A or WT FTR must be different. In the case of the
mutant C87A FTR a disulfide bond is made between two thio-
lates with the concomitant removal of two electrons by an
oxidant, which in our system is dissolved oxygen (Scheme 1). In
the case of WT FTR one disulfide bond, the active-site disulfide
of FTR, has to be opened before another one, between FTR and
Trx, can be formed, accompanied by the removal of one electron
(Scheme 2). The active-site disulfide of the FTR may be broken
by the attacking Trx, helped by the cluster draining the elec-
tron. We have indications that oxidants, e.g. ferrocyanide, or
mediators with more positive redox potentials than the FTR,
e.g. anthraquinone 2,6-disulfonic acid, accelerate the heterodu-
plex formation. Further experiments are needed to better un-
derstand the mechanism of heteroduplex formation.
According to the proposed reaction mechanism for Trx reduc-
tion by FTR, the heteroduplex represents the one-electron-
reduced reaction intermediate. This intermediate is thought to
be dissociated by an electron provided by ferredoxin. We incu-
bated the heteroduplexes with ferredoxin, reduced either pho-
tochemically with light and thylakoids or enzymatically with
NADPH and FNR. Surprisingly, in both reduction systems the
dissociation was independent of ferredoxin, i.e. FNR or thyla-
koids were capable of delivering electrons directly to the het-
eroduplex and releasing Trx. With the thylakoids we even
observed dissociation in the dark, which, however, was in-
creased in the light. Thylakoids appear to contain some “reduc-
tants” capable of interacting with the FTR through the Fe-S
cluster or acting directly on the mixed disulfide bond. We do not
know whether these ferredoxin-independent reductions occur
in vivo or only under our in vitro conditions. Our experiments
do not provide any kinetic information. It may well be that in
vivo the reduction by ferredoxin is by far the most efficient and
therefore the preferred mechanism.
Among the chemical reductants dithionite was the most ef-
ficient in reducing the mixed disulfide bond and dissociating
Trx. This corroborates earlier reports (11) and the results ob-
tained with mutant C57S showing that dithionite alone is
capable of reducing the Fe-S cluster in analogues of the one-
electron-reduced intermediate. The electrons are probably fun-
neled through the cluster to Cys-87, which becomes the attack-
ing nucleophile. Thereby the cluster is reduced as seen by the
spectral change. In the C87A mutant the reduction by dithio-
nite is not possible because of the already reduced cluster and
the absence of Cys-87, and the mixed disulfide bond cannot be
broken. The reduction of the reaction intermediates or their
analogues without the need of ferredoxin contrasts with the
fact that the disulfide bridge of resting FTR can only be opened
by reduced ferredoxin or some reduced mediators (10, 22), a
difference we cannot currently explain with our results.
The redox potentials of the mixed disulfide bonds between
FTR and Trxs are 40–50 mV more positive than the potential
of the active-site disulfide of FTR (midpoint redox potential
(Em), pH 7.0  320 mV). These significantly more positive
redox potentials make the second step of Trx reduction, the
liberation of reduced Trx, a more favorable reaction. The het-
eroduplex between mutant FTR C87A and Trx f C49S dis-
played quite a different behavior. At potentials lower than
280 mV, down to 390 mV, only a partial dissociation was
observed. This is probably because this mutant FTR cannot
reform an active-site disulfide. Further spectroscopic studies
will provide more information on the properties of the different
mutant FTRs.
The heteroduplexes were able to interact with ferredoxin
non-covalently, thus forming triple complexes with a 1:1:1 com-
ponent ratio and confirming nicely the proposed interaction
scheme (8). Titrations of the heteroduplexes with ferredoxin
yielded difference spectra that were identical to those obtained
with FTR alone, and the affinities were also essentially the
same. These observations suggest that the FTR is not subjected
to major structural changes following the binding of Trxs. De-
tailed information on these aspects will be provided by the
structural analyses of the different protein-protein complexes.
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